Eran Ben-Arye1,2,3,4, Jamal Mahajna5, Radi Aly6, Mohammed Saleem Ali-Shtayeh7, Yedidia Bentur8, Efraim Lev9, Gary Deng10, Noah Samuels11,12,13. 1. Integrative Oncology Program, Haifa and Western Galilee Oncology Service, Clalit Health Services, Haifa, Israel. eranben@netvision.net.il. 2. Lin Medical Center, Affiliated with the Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. eranben@netvision.net.il. 3. Complementary and Traditional Medicine Unit, Department of Family Medicine, Affiliated with the Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. eranben@netvision.net.il. 4. The Oncology Service, Lin Medical Center, 35 Rothschild St., Haifa, Israel. eranben@netvision.net.il. 5. Cancer Drug Discovery Program, Galilee Technology Center, Kiryat Shmona, Israel. 6. Department of Plant Pathology and Weed Research, ARO, Newe-Yaar Research Center, Ramat Yishay, Israel. 7. Biodiversity and Biotechnology Research Unit, Biodiversity and Environmental Research Center, BERC, Til, Nablus, Palestine. 8. Israel Poison Information Center, Section of Clinical Pharmacology and Toxicology, Rambam Health Care Campus, The Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. 9. Department of Eretz Israel Studies, University of Haifa, Haifa, Israel. 10. Integrative Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. 11. Integrative Oncology Program, Haifa and Western Galilee Oncology Service, Clalit Health Services, Haifa, Israel. 12. Lin Medical Center, Affiliated with the Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. 13. Tal Center for Integrative Medicine, Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel.
Abstract
CONTEXT AND OBJECTIVES: The unmonitored use of herbal medicinal remedies by patients with cancer presents a significant challenge to oncology healthcare professionals. We describe an increasingly popular herbal "wonder drug," Ephedra foeminea (Alanda in Arabic), whose use has spread from the Palestinian patient population throughout the Middle East. We conducted a multicentered and multidisciplinary collaborative research effort in order to understand the potential benefits and harms of this popular herbal remedy. METHODS: We conducted an in-depth search of the medical literature, both traditional and modern, for any mention of the clinical use of Alanda for the treatment of cancer. We then tested the remedy, first for toxic ephedra alkaloid components and then for anticancer effects, as well as effects on the cytotoxic activity of chemotherapy agents (cisplatin and carboplatin) on breast cancer cell cultures. RESULTS: We found no mention in the literature, both conventional and traditional, on the use of Alanda for the treatment of cancer. Laboratory testing did not find any toxic components (i.e., ephedra alkaloids) in the preparation. However, in vitro exposure to Alanda led to a reduced cytotoxic effect of chemotherapy on breast cancer cell cultures. CONCLUSIONS: The use of an integrative ethnobotanical, laboratory and clinical research-based approach can be extremely helpful when providing nonjudgmental and evidence-based guidance to patients with cancer, especially on the use of traditional herbal medicine. The effectiveness and safety of these products need to be examined by integrative physicians who are dually trained in both complementary medicine and supportive cancer care.
CONTEXT AND OBJECTIVES: The unmonitored use of herbal medicinal remedies by patients with cancer presents a significant challenge to oncology healthcare professionals. We describe an increasingly popular herbal "wonder drug," Ephedra foeminea (Alanda in Arabic), whose use has spread from the Palestinian patient population throughout the Middle East. We conducted a multicentered and multidisciplinary collaborative research effort in order to understand the potential benefits and harms of this popular herbal remedy. METHODS: We conducted an in-depth search of the medical literature, both traditional and modern, for any mention of the clinical use of Alanda for the treatment of cancer. We then tested the remedy, first for toxic ephedra alkaloid components and then for anticancer effects, as well as effects on the cytotoxic activity of chemotherapy agents (cisplatin and carboplatin) on breast cancer cell cultures. RESULTS: We found no mention in the literature, both conventional and traditional, on the use of Alanda for the treatment of cancer. Laboratory testing did not find any toxic components (i.e., ephedra alkaloids) in the preparation. However, in vitro exposure to Alanda led to a reduced cytotoxic effect of chemotherapy on breast cancer cell cultures. CONCLUSIONS: The use of an integrative ethnobotanical, laboratory and clinical research-based approach can be extremely helpful when providing nonjudgmental and evidence-based guidance to patients with cancer, especially on the use of traditional herbal medicine. The effectiveness and safety of these products need to be examined by integrative physicians who are dually trained in both complementary medicine and supportive cancer care.
Authors: Benjamin Koehl; Karsten Muenstedt; Oliver Micke; Ralph Muecke; Jens Buentzel; Christoph Stoll; Franz Josef Prott; Gabriele Dennert; Bianca Senf; Jutta Huebner Journal: Oncol Res Treat Date: 2014-01-24 Impact factor: 2.825
Authors: E Ben-Arye; E Massalha; G Bar-Sela; M Silbermann; A Agbarya; B Saad; E Lev; E Schiff Journal: Ann Oncol Date: 2014-01-07 Impact factor: 32.976
Authors: Eran Ben-Arye; Amneh M A Hamadeh; Elad Schiff; Rana M Jamous; Jamal Dagash; Rania M Jamous; Abed Agbarya; Gil Bar-Sela; Eyas Massalha; Michael Silbermann; Mohammed Saleem Ali-Shtayeh Journal: J Pain Symptom Manage Date: 2014-12-10 Impact factor: 3.612
Authors: James M Metz; Pamela Devine; Albert DeNittis; Heather Jones; Margaret Hampshire; Joel Goldwein; Richard Whittington Journal: Int J Radiat Oncol Biol Phys Date: 2003-07-15 Impact factor: 7.038
Authors: Eric Zadok Mpingirika; Ahmed El Hosseiny; Sheri Magdy Saleeb Bakheit; Rami Arafeh; Asma Amleh Journal: Biomed Res Int Date: 2020-07-09 Impact factor: 3.411